About Orflo
Orflo is a Healthcare company based in Ketchum (United States) founded in 2003, and was acquired by Gemini Bio in November 2019. Instrumentation for cell and protein analysis is developed and marketed. Orflo has raised $4.36 million across 3 funding rounds from investors including Gemini Bio, Broadoak Capital Partners and Research Corporation Technologies. Orflo offers products and services including Moxi GO II, Moxi V, and Moxi Z. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Cell Biology. Its competitors include Cytek Biosciences, ACEA Biosciences and Accuri Cytometers; 3 of its 3 listed competitors have raised funding.
Company details
Orflo Technologies is developing and marketing instrumentation for the cell and protein analysis. Orflos instrumentation is a patent protected µFlow Cell Cassette. Through the combination of impedance (Coulter Principle) and fluorescence based flow cytometry Orflos instruments provide cell analysis by directly measuring fluorescence and cell volume simultaneously. The first product developed by Orflo is a hand-held cell counter. Later, Orflo extended single use cell counting to flow cytometry and multiplex bead-based assays for cell and protein research. After that, Moxi Flow and zEPI Flow platforms are launched which provides better cell and protein analysis; apoptosis, multiplexedflow cytometry, viability, RFP transfection efficiency checks, cell cycle, phagocytosis, multiplexed cytokine analysis.
- Total Equity Funding$4.36M (USD)
in 3 rounds
- Latest Funding Round$175K (USD), Series A
Apr 2017
- InvestorsGemini Bio
& 2 more
- Acquired byGemini Bio
(Nov 2019)
Products & Services of Orflo
Orflo offers a comprehensive portfolio of products and services, including Moxi GO II, Moxi V, and Moxi Z.
Mini device for accurate cell counting and fluorescence detection.
Tool for precise cell count, size, and viability measurements.
Compact system for reliable cell counting in research.
Apps and channels of Orflo
its YouTube channel Orflo Technologies has 17 subscribers and 25 videos.
Videos from Orflo
The most watched videos on Orflo's YouTube channel, Orflo Technologies (17 subscribers). Click a video to play it here.
More on Orflo Technologies.
Funding Insights of Orflo
Orflo has successfully raised a total of $4.36M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $175 thousand completed in April 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.36M
- Total Rounds 3
- Last Round Series A — $175,000
- First Round $1.18M
(Nov 2013)
- Investors Count 2
All 3 funding rounds of Orflo with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2017 | $175,000 | Series A | – | – | – |
| Apr 2014 | $3M | Series A | – | – | |
| Nov 2013 | $1.18M | Seed | – | – | – |
3 investors in total: 3 institutional.
Investors in Orflo
Orflo has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Gemini Bio, Broadoak Capital Partners and Research Corporation Technologies.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Research Corporation Technologies is engaged in licensing biomedical technologies. | rctech.com | Tucson, United States | ||
Investment banking services are offered in the United States. | 2006 | broadoak.com | Bethesda, United States | |
Supplement reagents for cell and gene therapy are manufactured. | 1985 | geminibio.com | West Sacramento, United States |
Investor details for Orflo
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Orflo
4 dated milestones of Orflo across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Orflo is founded.
- Funding First funding round of $1.2M.
- Funding Latest funding round, Series A, of $175K.
- Exit Acquired by Gemini Bio.
Competitors of Orflo
Orflo has 3 listed competitors in our database, 3 of them funded. They include Cytek Biosciences, ACEA Biosciences and Accuri Cytometers.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cytekbio.com | 2014 | San Francisco, United States | $132M | 676 | Advanced flow cytometry systems are manufactured for research applications. | |
| aceabio.com | 2002 | San Diego, United States | $37.89M | 5,968 | Instruments for life science research are developed and marketed. | |
| accuricytometers.com | 2004 | Ann Arbor, United States | $30.91M | Compact flow cytometers for cell analysis are developed and provided. |
Detailed competitors of Orflo
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Orflo (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Orflo
Complete news archive for Orflo
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Orflo
Orflo was founded in 2003 and raised its 1st funding round 10 years after it was founded.
Orflo is headquartered in Ketchum, United States. It is registered at Ketchum, Idaho, United States.
Orflo is a funded company, having raised a total of $4.36M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.18M, raised on Nov 2013.
Orflo Technologies is developing and marketing instrumentation for the cell and protein analysis. Orflos instrumentation is a patent protected µFlow Cell Cassette. Through the combination of impedance (Coulter Principle) and fluorescence based flow cytometry Orflos instruments provide cell analysis by directly measuring fluorescence and cell volume simultaneously. The first product developed by Orflo is a hand-held cell counter. Later, Orflo extended single use cell counting to flow cytometry and multiplex bead-based assays for cell and protein research. After that, Moxi Flow and zEPI Flow platforms are launched which provides better cell and protein analysis; apoptosis, multiplexedflow cytometry, viability, RFP transfection efficiency checks, cell cycle, phagocytosis, multiplexed cytokine analysis.
Orflo's top competitors include Cytek Biosciences, Accuri Cytometers and ACEA Biosciences.
Orflo offers Moxi GO II, Moxi V, and Moxi Z.
Orflo has 3 investors. Key investors include Gemini Bio, Broadoak Capital Partners, and Research Corporation Technologies.
Yes. Orflo was acquired by Gemini Bio in November 2019.